Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
U.S. NeuroSurgical Holdings, Inc. (USNU)
|
|
Income Statement |
|
|
|
Standardized | As Reported |
Annual | Quarterly | TTM |
|
In millions, except per share items | Jun-30-23 | Mar-31-23 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 |
| 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-K/A | 10-Q | 10-Q |
Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Revenue growth | | | | | -100.0% | -100.0% | -100.0% | -100.0% |
Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross margin | | | | | | | | |
Selling, general and administrative [+] | 0.2 | 0.1 | 0.2 | 0.3 | 0.4 | 0.2 | 0.3 | 0.2 |
General and administrative | | | | | | 0.2 | | |
Equity in earnings | -0.3 | 0.0 | -0.2 | -1.0 | -0.1 | -0.1 | -0.1 | -0.1 |
EBITDA [+] | | | | | | | | |
Depreciation and amortization | | | | | | | | |
EBIT [+] | -0.5 | -0.1 | -0.4 | -1.3 | -0.5 | -0.4 | -0.3 | -0.4 |
EBIT growth | -60.4% | -74.2% | 9.3% | 235.9% | -191.6% | -218.7% | -251.3% | -917.0% |
EBIT margin | | | | | | | | |
Interest expense | | | | | | | | 0.0 |
Interest expense | | | | | | | | 0.0 |
Other income (expense), net [+] | | | | | | 0.0 | 0.0 | |
Other | | | | | | 0.0 | 0.0 | -0.1 |
Pre-tax income | -0.5 | -0.1 | -0.4 | -1.3 | -0.5 | -0.4 | -0.3 | -0.4 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.0 | 0.2 |
Tax rate | 0.0% | 0.0% | | | | | | |
Minority interest | -0.1 | 0.0 | -0.1 | -0.2 | -0.1 | -0.1 | | |
Net income | -0.4 | -0.1 | -0.3 | -1.1 | -0.4 | -0.5 | -0.4 | -0.6 |
Net margin | | | | | | | | |
|
Basic EPS [+] | ($0.05) | ($0.01) | ($0.04) | ($0.14) | ($0.05) | ($0.06) | ($0.05) | ($0.08) |
Growth | -60.9% | -74.5% | -8.8% | 77.8% | -244.2% | -437.6% | -314.6% | -1471.1% |
Diluted EPS [+] | ($0.05) | ($0.01) | ($0.04) | ($0.14) | ($0.05) | ($0.06) | ($0.05) | ($0.08) |
Growth | -60.9% | -74.5% | -8.8% | 77.8% | -244.2% | -437.6% | -314.6% | -1471.1% |
|
Shares outstanding (basic) [+] | 7.9 | 7.8 | 7.8 | 7.8 | 7.8 | 7.8 | 7.8 | 7.8 |
Growth | 1.3% | 0.6% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Shares outstanding (diluted) [+] | 7.9 | 7.8 | 7.8 | 7.8 | 7.8 | 7.8 | 7.8 | 7.8 |
Growth | 1.3% | 0.6% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|